CNBX Pharmaceuticals Inc.
CNBX · OTCMCIK 1343009fmd_0BS8ZA60Q95WVSHEK67EDWQB29Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Sep 15, 2004 to May 31, 2026, 69 periods
Latest annual · FY2025
Millions- Total revenues
- 0
- Operating income
- (0)
- Net income
- (0)
Latest quarter · Q3 FY2026
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (0)
- Net income
- (0)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2022 to FY2025
- n/m
- Revenue, 5 yearsFY2020 to FY2025
- n/m
- Net income, 5 yearsFY2020 to FY2025
- n/m
CNBX Pharmaceuticals Inc. (CNBX) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $0 | $130,074 | -100% | 10-K 2025-12-01 · proof |
| Operating income | -$271,691 | -$583,139 | 10-K 2025-12-01 · proof | |
| Net income | -$313,976 | -$695,198 | 10-K 2025-12-01 · proof | |
| Cash from operating activities | -$171,305 | -$244,269 | 10-K 2025-12-01 · proof | |
| Total assets | $18,437 | $31,383 | -41.3% | 10-K 2025-12-01 · proof |
| Total liabilities | $2.5 million | $2.5 million | +0.1% | 10-K 2025-12-01 · proof |
| Cash and cash equivalents | $15,111 | $26,416 | -42.8% | 10-K 2025-12-01 · proof |
- What was CNBX Pharmaceuticals Inc. (CNBX)'s revenue in fiscal 2025?
- CNBX Pharmaceuticals Inc. (CNBX) reported revenue of $0 for fiscal 2025 (the year ended Aug 31, 2025), against $130,074 the year before (-100%). Source: the 10-K filed with the SEC on Dec 1, 2025. SEC
- What was CNBX Pharmaceuticals Inc. (CNBX)'s operating income in fiscal 2025?
- CNBX Pharmaceuticals Inc. (CNBX) reported operating income of -$271,691 for fiscal 2025 (the year ended Aug 31, 2025), against -$583,139 the year before. Source: the 10-K filed with the SEC on Dec 1, 2025. SEC
- What was CNBX Pharmaceuticals Inc. (CNBX)'s net income in fiscal 2025?
- CNBX Pharmaceuticals Inc. (CNBX) reported net income of -$313,976 for fiscal 2025 (the year ended Aug 31, 2025), against -$695,198 the year before. Source: the 10-K filed with the SEC on Dec 1, 2025. SEC
- What was CNBX Pharmaceuticals Inc. (CNBX)'s cash from operating activities in fiscal 2025?
- CNBX Pharmaceuticals Inc. (CNBX) reported cash from operating activities of -$171,305 for fiscal 2025 (the year ended Aug 31, 2025), against -$244,269 the year before. Source: the 10-K filed with the SEC on Dec 1, 2025. SEC
- What are CNBX Pharmaceuticals Inc. (CNBX)'s total assets?
- As of Aug 31, 2025, CNBX Pharmaceuticals Inc. (CNBX) reported total assets of $18,437, against $31,383 a year earlier (-41.3%). Source: the 10-K filed with the SEC on Dec 1, 2025. SEC
- What are CNBX Pharmaceuticals Inc. (CNBX)'s total liabilities?
- As of Aug 31, 2025, CNBX Pharmaceuticals Inc. (CNBX) reported total liabilities of $2.5 million, against $2.5 million a year earlier (+0.1%). Source: the 10-K filed with the SEC on Dec 1, 2025. SEC
- What are CNBX Pharmaceuticals Inc. (CNBX)'s cash and cash equivalents?
- As of Aug 31, 2025, CNBX Pharmaceuticals Inc. (CNBX) reported cash and cash equivalents of $15,111, against $26,416 a year earlier (-42.8%). Source: the 10-K filed with the SEC on Dec 1, 2025. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:CNBX&period_type=annual&limit=5"Information only, not investment advice.